Skip to main content
Alan Moses, MD, Endocrinology, Plainsboro, NJ

AlanCMosesMD

Endocrinology • Plainsboro, NJ

Diabetes, Lipid Metabolism

Physician

Join to view full profile

Dr. Moses is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Moses' full profile

Already have an account?

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1979
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1974 - 1975
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1973

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1979 - 2025

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1990

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Virta Health Highlights Lasting, Transformative Health Improvements in 5-Year Diabetes Reversal Study
    Virta Health Highlights Lasting, Transformative Health Improvements in 5-Year Diabetes Reversal StudyJune 6th, 2022
  • BiomX Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
    BiomX Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateMarch 31st, 2021
  • BiomX : Appoints Paul Sekhri and Alan Moses, M.D., to Board of Directors
    BiomX : Appoints Paul Sekhri and Alan Moses, M.D., to Board of DirectorsOctober 5th, 2020
  • Join now to see all

Grant Support

  • Insulin &Insulin LIKE Growth Factor 1--Insulin ResistanNational Center For Research Resources2000–2002
  • Characterization Of Insulin &Insulin LIKE Growth Factor ResponsesNational Center For Research Resources1999–2002
  • Inhaled Human Insulin VS Usual Subcutaneous Insulin Therapy In IDDMNational Center For Research Resources1998–2002
  • Troglitazone In Moderate To Severe Insulin ResistanceNational Center For Research Resources1997–2002
  • Insulin And Insulinlike Growth Factor ResponsesNational Center For Research Resources1996–2002
  • Troglitazone With/Without Insulin For Insulin Requiring Patients With NIDDMNational Center For Research Resources1998–1999
  • Inhaled Human Insulin VS Usual SQ Human Insulin Therapy In NIDDMNational Center For Research Resources1998–1999
  • Biological Effect And Clinical Efficacy Of Octreotide, Analog Of SomatostatinNational Center For Research Resources1996–1999
  • Pilot Study Of A Novel, Noninvasive Method Of Blood Glucose MonitoringNational Center For Research Resources1997
  • Lyspro VS U-500 Insulin In Treatment Of Antibody Mediated Insulin ResistanceNational Center For Research Resources1997
  • General Clinical Research CenterNational Center For Research Resources1996–1997
  • Effect Of Lyspro VS U-500 Human Insulin In Treatment Of Antibody Mediated IRNational Center For Research Resources1996
  • Dose Finding Study Of RH IGF I In Type II DiabetesNational Center For Research Resources1996
  • Mechanism Underlying Local Insulin/Latex AllergyNational Center For Research Resources1995–1996
  • Characterization Of Insulin And Insulin-Like Growth Factor I ResponsesNational Center For Research Resources1995–1996
  • Recombinant Human IGF-I In The Treatment Of Type II Diabetes MellitusNational Center For Research Resources1995
  • Dose Finding Study Of Rhigh I In Type II DiabetesNational Center For Research Resources1995
  • Compassionate Use Of Growth Releasing HormoneNational Center For Research Resources1995

Professional Memberships

Dr. Alan Moses, Dr. Alan Moses, MD, Dr. A Moses, Dr. Alan C Moses